09.04.2021 16:37:47
|
Stock Alert: Greenwich LifeSciences Gains 6%
(RTTNews) - Shares of Greenwich LifeSciences, Inc. (GLSI) are up more than 6% Friday morning on robust immune response data from the Phase 2b study of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery, over 5 years of follow-up.
The data were published at the American Association for Cancer Research (AACR) annual meeting.
GLSI, currently at $53.58, has been trading in the range of $3.26- $158.07 in the last one year.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Greenwich LifeSciences Inc Registered Shsmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Greenwich LifeSciences Inc Registered Shsmehr Analysen
Aktien in diesem Artikel
Greenwich LifeSciences Inc Registered Shs | 11,85 | -0,84% |
|